comparemela.com

Latest Breaking News On - Adrien bernstein - Page 1 : comparemela.com

SUO 2020: Impact of PSMA Scans on Clinical Management-Point/Counterpoint

SUO 2020: Impact of PSMA Scans on Clinical Management-Point/Counterpoint (UroToday.com) To conclude the advances in prostate cancer session Drs. Matthew Cooperberg and Tanya Dorff debated whether prostate-specific membrane antigen (PSMA) imaging should be routinely used in the clinical management of prostate cancer. Earlier this week the Food and Drug Administration (FDA) approved Gallium 68 PSMA-11 as the first prostate membrane specific antigen based tracer for PET CT imaging. The tracer was specifically approved to aid in the detection of metastatic prostate cancer. Despite the approval, guidelines have yet to clarify the role of PSMA versus conventional imaging. Dr. Cooperberg began the session by providing the argument against the widespread adoption of PSMA-PET imaging into our current prostate cancer algorithms. He acknowledged the abundance of literature demonstrating superior detection rates with PSMA-PET over conventional imaging, even in the setting of very low pro

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.